Outcomes With Immune Checkpoint Inhibitors Similar for Older, Younger Patients
Older patients have divergent immune phenotypes at baseline that persist during immune checkpoint inhibitor therapy
Hydroxyurea Has Sustained Clinical Benefits in Children With Sickle Cell Anemia
Fewer ED visits per year and fewer hospital days per year seen in association with hydroxyurea use
Food Companies Race to Replace Artificial Colors With Natural Alternatives
AACR: Incidence-Based Mortality Dropping for Young Women With Breast Cancer
Highest incidence-based mortality seen in non-Hispanic Black women, with declines pronounced from 2016, narrowing gap with other racial groups
AACR: Nonsurgical Treatment Feasible for Mismatch Repair-Deficient Tumors
Neoadjuvant PD-1 blockade with dostarlimab enables nonoperative management strategy for large proportion of patients
Ultraprocessed Food Intake Contributes to All-Cause Mortality
4 to 14 percent of premature deaths attributable to ultraprocessed foods in countries with low, high intake
Exercise, Rehab Services Can Be Integrated Into Breast Cancer Care
Patients provide positive feedback for the clinical workflow
Landmark Women’s Health Study Saved From Funding Cuts
Efanesoctocog Alfa Not Cost-Effective for Prophylaxis in Hemophilia A
Efanesoctocog alfa needs to be priced at <53 and <59 percent of current price for conventional and distributional cost-effectiveness
DDW: Systematic Program Increases Likelihood of Up-to-Date Colorectal Cancer Screening
Approximate doubling of up-to-date status seen among Asian, Black, Hispanic, White patients, with corresponding decrease in CRC incidence, deaths
